Manufacturers

Novolot Pharma Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Medicine Type

drugs

Introduction

In Treatment of Type 2 diabetes mellitus Glimelot MV 2mg/500mg/0.2mg Tablet is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. It also helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs. u003cbr>Glimelot MV 2mg/500mg/0.2mg Tablet will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.

Benefits

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimelot MV 2mg/500mg/0.2mg Tablet is to be taken empty stomach.

Description

Glimelot MV 2mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.Glimelot MV 2mg/500mg/0.2mg Tablet should be taken with food. Take it regularly at the same time each day to get the most benefit. Your doctor will decide what dose is best for you and this may change from time to time according to how it is working according to your blood sugar levels.Keep taking this medicine, even if you feel well or your blood sugar levels are controlled. If you stop it without consulting your doctor, your blood sugar levels could rise and put you at risk of kidney damage, blindness, nerve problems and loss of limbs. Remember that it is only part of a treatment program that should also include a healthy diet, regular exercise, and weight reduction as advised by your doctor. Your lifestyle plays a big part in controlling diabetes.The most common side effect of Glimelot MV 2mg/500mg/0.2mg Tablet is low blood glucose levels (hypoglycemia). Make sure you recognize the signs of having low blood glucose levels, such as sweating, dizziness, headache, and shaking and know how to deal with it. To prevent this, it's important to have regular meals and always carry a fast-acting source of glucose such as sugary food or fruit juice with you. Drinking alcohol can also increase your risk of low blood sugar levels and should be avoided. Other side effects that may be seen on taking this medicine include taste changes, nausea, diarrhea, stomach pain, headache, edema (swelling), blurred vision, bone fracture, and upper respiratory tract infection. Some people may find that they put on weight with this medicine.You should not take it if you have type 1 diabetes mellitus, if you have diabetic ketoacidosis (high levels of acid in your blood), or if you have severe kidney or liver disease. Before taking this medicine, tell your doctor if you have ever had heart disease. It may not be suitable. Pregnant or breastfeeding women should also consult their doctor before taking it. Your blood sugar levels should be checked regularly and your doctor may also advise blood tests to monitor your blood cell counts and liver function.

How To Use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimelot MV 2mg/500mg/0.2mg Tablet is to be taken empty stomach.

Safety Advise

- Alcohol : UNSAFE

It is unsafe to consume alcohol with Glimelot MV 2mg/500mg/0.2mg Tablet. | - Pregnancy : CONSULT YOUR DOCTOR

Glimelot MV 2mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor. | - Breast feeding : CONSULT YOUR DOCTOR

Glimelot MV 2mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby. | - Driving : CAUTION

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur. | - Kidney : UNSAFE

Glimelot MV 2mg/500mg/0.2mg Tablet is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor.Use of Glimelot MV 2mg/500mg/0.2mg Tablet is, however, not recommended in patients with severe kidney disease. | - Liver : CAUTION

Glimelot MV 2mg/500mg/0.2mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimelot MV 2mg/500mg/0.2mg Tablet may be needed. Please consult your doctor.Glimelot MV 2mg/500mg/0.2mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

If Miss

If you miss a dose of Glimelot MV 2mg/500mg/0.2mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.

Packaging Detail

strip of 10 tablets

Package

Strip

Qty

10

Product Form

Tablet

Prescription Required

Prescription Required

Fact Box

Habit Forming :: No|Therapeutic Class :: ANTI DIABETIC

Primary Use

Treatment of Type 2 diabetes mellitus

Storage

Store below 30°C

Use Of

Treatment of Type 2 diabetes mellitus

Common Side Effect

Nausea | Diarrhea | Abdominal pain | Hypoglycemia (low blood glucose level) | Loss of appetite

Alcoholinteraction

UNSAFE

Pregnancyinteraction

CONSULT YOUR DOCTOR

Lactationinteraction

CONSULT YOUR DOCTOR

Drivinginteraction

CAUTION

Kidneyinteraction

UNSAFE

Liverinteraction

CAUTION

Manufacturer Address

19-105/1, V.V Nagar Saidabad Hyderabad Hyderabad TG 500060 IN

Q A

Q. What is Glimelot MV 2mg/500mg/0.2mg Tablet?::: Glimelot MV 2mg/500mg/0.2mg Tablet is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medicine is used in the treatment of type 2 diabetes mellitus (DM). It improves the blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers the blood glucose levels by increasing the release of insulin from the pancreas. Metformin works by lowering the glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor which lowers the postprandial (after meals) glucose levels in the body. This combination is not indicated for the treatment of Type 1 DM.| Q. What are the possible side effects of Glimelot MV 2mg/500mg/0.2mg Tablet?::: The use of Glimelot MV 2mg/500mg/0.2mg Tablet is associated with common side effects like hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.| Q. Are there any specific conditions in which Glimelot MV 2mg/500mg/0.2mg Tablet should not be taken?::: The use of Glimelot MV 2mg/500mg/0.2mg Tablet should be avoided in patients with known allergy to any of the components or excipients of this medicine. The use of this medicine is also avoided in patients with moderate to severe kidney disease and in patients with inflammatory bowel disease, colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis.| Q. Is it safe to take alcohol while I am also taking Glimelot MV 2mg/500mg/0.2mg Tablet?::: No, it is not safe to take Glimelot MV 2mg/500mg/0.2mg Tablet along with alcohol. It may lower your low blood sugar levels (hypoglycemia) and can increase the chances of lactic acidosis.| Q. Can the use of Glimelot MV 2mg/500mg/0.2mg Tablet cause hypoglycemia?::: Yes, the use of Glimelot MV 2mg/500mg/0.2mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It happens more often if you miss or delay your food, drink alcohol, over-exercise or take other antidiabetic medicine along with it. So, regular monitoring of blood sugar level is important. Always keep glucose tablets, honey or fruit juice with you.| Q. What are the instructions for the storage and disposal of Glimelot MV 2mg/500mg/0.2mg Tablet?::: Keep this medicine in the packet or the container it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.

How It Works

Glimelot MV 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:.

Marketer Details

Novolot Pharma Pvt Ltd | 19-105/1, V.V Nagar Saidabad Hyderabad Hyderabad TG 500060 IN

Reference

Glimepiride. Bridgewater, New Jersey: Sanofi-Aventis U.S. LLC.; 2009. [Accessed 08 Apr. 2019] (online) Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020496s021lbl.pdf | Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company. [Accessed 08 Apr. 2019] (online) Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020357s031,021202s016lbl.pdf | Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7. [Accessed 08 Apr. 2019] (online) Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919386/ | Glimepiride+Metformin+Voglibose [Product Monograph]. Punjab, India: Centaur Pharmaceuticals Pvt. Ltd.; 2018. [Accessed 25 Oct. 2021] (online) Available from: https://www.centaurpharma.com/downloads/Glimitab-MV2018.pdf | Metformin Hydrochloride (Prolonged Release), Voglibose & Glimepiride [Patient Information Sheet]. Ahmedabad, Gujarat: TORRENT PHARMACEUTICALS LTD.; 2015. [Accessed 28th Sept. 2023] (online) Available from: https://www.torrentian.com/pisheet/Upload/PI_Sheet/2688.pdf